Erzberger, J. P. & Berger, J. M. Evolutionary relationships and structural mechanisms of AAA+ proteins. Annu. Rev. Biophys. Biomol. Struct. 35, 93–114 (2006).Article
CAS
PubMed
Google Scholar
Bodnar, N. & Rapoport, T. Toward an understanding of the Cdc48/p97 ATPase. F1000Res 6, 1318 (2017).Article
PubMed
PubMed Central
Google Scholar
Ye, Y., Tang, W. K., Zhang, T. & Xia, D. A mighty “protein extractor” of the cell: structure and function of the p97/CDC48 ATPase. Front. Mol. Biosci. 4, 39 (2017).Article
PubMed
PubMed Central
Google Scholar
Stach, L. & Freemont, P. S. The AAA+ ATPase p97, a cellular multitool. Biochem. J 474, 2953–2976 (2017).Article
CAS
PubMed
Google Scholar
Ye, Y., Shibata, Y., Yun, C., Ron, D. & Rapoport, T. A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429, 841–847 (2004).Article
CAS
PubMed
Google Scholar
Ju, J.-S. et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.J. Cell Biol. 187, 875–888 (2009).Article
CAS
PubMed
PubMed Central
Google Scholar
Bug, M. & Meyer, H. Expanding into new markets-VCP/p97 in endocytosis and autophagy. J. Struct. Biol. 179, 78–82 (2012).Article
CAS
PubMed
Google Scholar
Tresse, E. et al. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6, 217–227 (2010).Article
CAS
PubMed
Google Scholar
Antonin, W. & Neumann, H. Chromosome condensation and decondensation during mitosis. Curr. Opin. Cell Biol. 40, 15–22 (2016).Article
CAS
PubMed
Google Scholar
Uchiyama, K. et al. VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo.J. Cell Biol. 159, 855–866 (2002).Article
CAS
PubMed
PubMed Central
Google Scholar
Latterich, M., Fröhlich, K. U. & Schekman, R. Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes. Cell 82, 885–893 (1995).Article
CAS
PubMed
Google Scholar
Rabouille, C., Levine, T. P., Peters, J. M. & Warren, G. An NSF-like ATPase, p97, and NSF mediate cisternal regrowth from mitotic Golgi fragments. Cell 82, 905–914 (1995).Article
CAS
PubMed
Google Scholar
Kondo, H. et al. p47 is a cofactor for p97-mediated membrane fusion. Nature 388, 75–78 (1997).Article
CAS
PubMed
Google Scholar
Hänzelmann, P. & Schindelin, H. The interplay of cofactor interactions and post-translational modifications in the regulation of the AAA+ ATPase p97. Front. Mol. Biosci. 4, 21 (2017).Article
PubMed
PubMed Central
Google Scholar
Watts, G. D. J. et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377–381 (2004).Article
CAS
PubMed
Google Scholar
Mehta, S. G. et al. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia. Clin. Genet. 83, 422–431 (2013).Article
CAS
PubMed
Google Scholar
Evangelista, T., Weihl, C. C., Kimonis, V., Lochmüller, H. & related diseases Consortium, V. C. P. 215th ENMC international workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands. Neuromuscul. Disord. 26, 535–547 (2016).Article
PubMed
PubMed Central
Google Scholar
Saracino, D. et al. Novel VCP mutations expand the mutational spectrum of frontotemporal dementia. Neurobiol. Aging 72, 187.e11–187.e14 (2018).Article
CAS
PubMed
Google Scholar
Schiava, M. et al. Clinical classification of variants in the valosin-containing protein gene associated with multisystem proteinopathy. Neurol. Genet. 9, e200093 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Tang, W. K. & Xia, D. Mutations in the human AAA+ Chaperone p97 and related diseases. Front. Mol. Biosci. 3, 79 (2016).Article
PubMed
PubMed Central
Google Scholar
Zhang, X. et al. Altered cofactor regulation with disease-associated p97/VCP mutations. Proc. Natl. Acad. Sci. USA. 112, E1705–E1714 (2015).CAS
PubMed
PubMed Central
Google Scholar
Franz, A., Ackermann, L. & Hoppe, T. Create and preserve: proteostasis in development and aging is governed by Cdc48/p97/VCP. Biochim. Biophys. Acta 1843, 205–215 (2014).Article
CAS
PubMed
Google Scholar
Ritz, D. et al. Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat. Cell Biol. 13, 1116–1123 (2011).Article
CAS
PubMed
PubMed Central
Google Scholar
Kim, N. C. et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron 78, 65–80 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Bartolome, F. et al. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron 78, 57–64 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Deshaies, R. J. Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy. BMC Biol. 12, 94 (2014).Article
PubMed
PubMed Central
Google Scholar
Gugliotta, G. et al. Valosin-containing protein/p97 as a novel therapeutic target in acute lymphoblastic leukemia. Neoplasia 19, 750–761 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Huryn, D. M., Kornfilt, D. J. P. & Wipf, P. P97: An emerging target for cancer, neurodegenerative diseases, and viral infections. J. Med. Chem. 63, 1892–1907 (2020).Article
CAS
PubMed
Google Scholar
Xia, D., Tang, W. K. & Ye, Y. Structure and function of the AAA+ ATPase p97/Cdc48p. Gene 583, 64–77 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Banerjee, S. et al. 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science 351, 871–875 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang, X. et al. Structure of the AAA ATPase p97. Mol. Cell 6, 1473–1484 (2000).Article
CAS
PubMed
Google Scholar
Hänzelmann, P. & Schindelin, H. Structural basis of ATP hydrolysis and intersubunit signaling in the AAA+ ATPase p97. Structure 24, 127–139 (2016).Article
PubMed
Google Scholar
Song, C., Wang, Q. & Li, C.-C. H. ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J. Biol. Chem 278, 3648–3655 (2003).Article
CAS
PubMed
Google Scholar
Wang, Q., Song, C. & Li, C.-C. H. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities. Biochem. Biophys. Res. Commun. 300, 253–260 (2003).Article
CAS
PubMed
Google Scholar
Davies, J. M., Brunger, A. T. & Weis, W. I. Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change. Structure 16, 715–726 (2008).Article
CAS
PubMed
Google Scholar
Puchades, C., Sandate, C. R. & Lander, G. C. The molecular principles governing the activity and functional diversity of AAA+ proteins. Nat. Rev. Mol. Cell Biol. 21, 43–58 (2020).Article
CAS
PubMed
Google Scholar
Xu, Y. et al. Active conformation of the p97-p47 unfoldase complex. Nat. Commun. 13, 2640 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Brunger, A. T. & DeLaBarre, B. NSF and p97/VCP: similar at first, different at last. FEBS Lett. 555, 126–133 (2003).Article
CAS
PubMed
Google Scholar
Stolz, A., Hilt, W., Buchberger, A. & Wolf, D. H. Cdc48: a power machine in protein degradation. Trends Biochem. Sci. 36, 515–523 (2011).Article
CAS
PubMed
Google Scholar
Niwa, H. et al. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. J. Biol. Chem. 287, 8561–8570 (2012).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang, X. et al. Conserved L464 in p97 D1-D2 linker is critical for p97 cofactor regulated ATPase activity. Biochem. J 478, 3185–3204 (2021).Article
CAS
PubMed
Google Scholar
Meyer, H. H., Kondo, H. & Warren, G. The p47 co-factor regulates the ATPase activity of the membrane fusion protein, p97. FEBS Lett. 437, 255–257 (1998).Article
CAS
PubMed
Google Scholar
Tang, W. K. et al. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J. 29, 2217–2229 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Schuller, J. M., Beck, F., Lössl, P., Heck, A. J. R. & Förster, F. Nucleotide-dependent conformational changes of the AAA+ ATPase p97 revisited. FEBS Lett. 590, 595–604 (2016).Article
CAS
PubMed
Google Scholar
Bulfer, S. L., Chou, T.-F. & Arkin, M. R. p97 disease mutations modulate nucleotide-induced conformation to alter protein-protein interactions. ACS Chem. Biol. 11, 2112–2116 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Buchberger, A., Schindelin, H. & Hänzelmann, P. Control of p97 function by cofactor binding. FEBS Lett. 589, 2578–2589 (2015).Article
CAS
PubMed
Google Scholar
Nandi, P. et al. Structural and functional analysis of disease-linked p97 ATPase mutant complexes. Int. J. Mol. Sci. 22, 8079 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Huang, R., Ripstein, Z. A., Rubinstein, J. L. & Kay, L. E. Cooperative subunit dynamics modulate p97 function. Proc. Natl. Acad. Sci. USA 116, 158–167 (2019).Article
CAS
PubMed
Google Scholar
Schuetz, A. K. & Kay, L. E. A Dynamic molecular basis for malfunction in disease mutants of p97/VCP. Elife 5, e20143 (2016).Article
PubMed
PubMed Central
Google Scholar
Schütz, A. K., Rennella, E. & Kay, L. E. Exploiting conformational plasticity in the AAA+ protein VCP/p97 to modify function. Proc. Natl. Acad. Sci. USA 114, E6822–E6829 (2017).Article
PubMed
PubMed Central
Google Scholar
Tang, W. K. & Xia, D. Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants. J. Biol. Chem. 288, 36624–36635 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Tang, W. K., Zhang, T., Ye, Y. & Xia, D. Structural basis for nucleotide-modulated p97 association with the ER membrane. Cell Discov. 3, 17045 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Caffrey, B. et al. AAA+ ATPase p97/VCP mutants and inhibitor binding disrupt inter-domain coupling and subsequent allosteric activation. J. Biol. Chem. 297, 101187 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Valimehr, S. et al. Molecular mechanisms driving and regulating the AAA+ ATPase VCP/p97, an important therapeutic target for treating cancer, neurological and infectious diseases. Biomolecules 13, 737 (2023).Huang, C., Li, G. & Lennarz, W. J. Dynamic flexibility of the ATPase p97 is important for its interprotomer motion transmission. Proc. Natl. Acad. Sci. USA 109, 9792–9797 (2012).Article
CAS
PubMed
PubMed Central
Google Scholar
Li, G., Huang, C., Zhao, G. & Lennarz, W. J. Interprotomer motion-transmission mechanism for the hexameric AAA ATPase p97. Proc. Natl. Acad. Sci. USA 109, 3737–3741 (2012).Article
CAS
PubMed
PubMed Central
Google Scholar
Chou, T.-F. et al. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc. Natl. Acad. Sci. USA 108, 4834–4839 (2011).Article
CAS
PubMed
PubMed Central
Google Scholar
Chou, T.-F., Li, K., Frankowski, K. J., Schoenen, F. J. & Deshaies, R. J. Structure-activity relationship study reveals ML240 and ML241 as potent and selective inhibitors of p97 ATPase. ChemMedChem 8, 297–312 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Anderson, D. J. et al. Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. Cancer Cell 28, 653–665 (2015).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou, H.-J. et al. Discovery of a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083).J. Med. Chem. 58, 9480–9497 (2015).Article
CAS
PubMed
Google Scholar
Gareau, A., Rico, C., Boerboom, D. & Nadeau, M.-E. In vitro efficacy of a first-generation valosin-containing protein inhibitor (CB-5083) against canine lymphoma. Vet. Comp. Oncol. 16, 311–317 (2018).Article
CAS
PubMed
Google Scholar
Tang, W. K., Odzorig, T., Jin, W. & Xia, D. Structural basis of p97 inhibition by the site-selective anticancer compound CB-5083. Mol. Pharmacol. 95, 286–293 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Leinonen, H. et al. A p97/valosin-containing protein inhibitor drug CB-5083 has a potent but reversible off-target effect on phosphodiesterase-6.J. Pharmacol. Exp. Ther 378, 31–41 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Roux, B. et al. Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor. Sci. Transl. Med. 13, eabg1168 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Alverez, C. et al. Allosteric indole amide inhibitors of p97: Identification of a novel probe of the ubiquitin pathway. ACS Med. Chem. Lett. 7, 182–187 (2016).Article
CAS
PubMed
Google Scholar
Alverez, C. et al. Structure-activity study of bioisosteric trifluoromethyl and pentafluorosulfanyl indole inhibitors of the AAA ATPase p97. ACS Med. Chem. Lett. 6, 1225–1230 (2015).Article
CAS
PubMed
PubMed Central
Google Scholar
LaPorte, M. G. et al. Optimization of phenyl indole inhibitors of the AAA+ ATPase p97. ACS Med. Chem. Lett. 9, 1075–1081 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Polucci, P. et al. Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships. J. Med. Chem. 56, 437–450 (2013).Article
CAS
PubMed
Google Scholar
Magnaghi, P. et al. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat. Chem. Biol. 9, 548–556 (2013).Article
CAS
PubMed
Google Scholar
Wang, F. et al. Allosteric p97 inhibitors can overcome resistance to ATP-competitive p97 inhibitors for potential anticancer therapy. ChemMedChem 15, 685–694 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Her, N.-G. et al. P97 composition changes caused by allosteric inhibition are suppressed by an on-target mechanism that increases the enzyme’s ATPase activity.Cell Chem. Biol. 23, 517–528 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Bouwer, M. F. et al. NMS-873 functions as a dual inhibitor of mitochondrial oxidative phosphorylation. Biochimie 185, 33–42 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
LaPorte, M. G. et al. Optimization of 1,2,4-triazole-based p97 inhibitors for the treatment of cancer. ACS Med. Chem. Lett. 14, 977–985 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
DeVore, K. & Chiu, P.-L. Probing structural perturbation of biomolecules by extracting Cryo-EM data heterogeneity. Biomolecules 12, 628 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Cheng, Y. Single-particle cryo-EM at crystallographic resolution. Cell 161, 450–457 (2015).Article
CAS
PubMed
PubMed Central
Google Scholar
Gao, H. et al. Cryo-EM structures of human p97 double hexamer capture potentiated ATPase-competent state. Cell Discov. 8, 19 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Hoq, M. R. et al. Affinity Capture of p97 with Small-Molecule Ligand Bait Reveals a 3.6 Å Double-Hexamer Cryoelectron Microscopy Structure. ACS Nano 15, 8376–8385 (2021).Article
CAS
PubMed
Google Scholar
Liu, S. et al. Cryo-EM structure of dodecamer human p97 in complex with NMS-873 reveals S765-G779 peptide plays critical role for D2 ring oligomerization. Biochem. Biophys. Res. Commun. 601, 146–152 (2022).Article
CAS
PubMed
Google Scholar
Yu, G. et al. Cryo-electron microscopy structures of VCP/p97 reveal a new mechanism of oligomerization regulation. iScience 24, 103310 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Pan, M. et al. Mechanistic insight into substrate processing and allosteric inhibition of human p97. Nat. Struct. Mol. Biol. 28, 614–625 (2021).Article
CAS
PubMed
Google Scholar
Wang, F., Li, S., Cheng, K.-W., Rosencrans, W. M. & Chou, T.-F. The p97 inhibitor UPCDC-30245 blocks endo-lysosomal degradation. Pharmaceuticals 15, 204 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, F., Li, S., Houerbi, N. & Chou, T.-F. Temporal proteomics reveal specific cell cycle oncoprotein downregulation by p97/VCP inhibition. Cell Chem. Biol. 29, 517–529.e5 (2022).Article
CAS
PubMed
Google Scholar
Segura-Cabrera, A. et al. A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase. Sci. Rep. 7, 44912 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, F. et al. Sulforaphane is synergistic with CB-5083 and inhibits colony formation of CB-5083-resistant HCT116 cells. ChemMedChem 17, e202200030 (2022).Article
CAS
PubMed
Google Scholar
Kobayashi, T., Tanaka, K., Inoue, K. & Kakizuka, A. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. J. Biol. Chem. 277, 47358–47365 (2002).Article
CAS
PubMed
Google Scholar
Halawani, D. et al. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol. Cell. Biol. 29, 4484–4494 (2009).Article
CAS
PubMed
PubMed Central
Google Scholar
Orme, C. M. & Bogan, J. S. The ubiquitin regulatory X (UBX) domain-containing protein TUG regulates the p97 ATPase and resides at the endoplasmic reticulum-golgi intermediate compartment. J. Biol. Chem. 287, 6679–6692 (2012).Article
CAS
PubMed
Google Scholar
Ewens, C. A. et al. The p97-FAF1 protein complex reveals a common mode of p97 adaptor binding.J. Biol. Chem 289, 12077–12084 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Stach, L. et al. Crystal structure of the catalytic D2 domain of the AAA+ ATPase p97 reveals a putative helical split-washer-type mechanism for substrate unfolding. FEBS Lett. 594, 933–943 (2020).Article
CAS
PubMed
Google Scholar
Creary, X., Chormanski, K., Peirats, G. & Renneburg, C. Electronic properties of triazoles. Experimental and computational determination of carbocation and radical-stabilizing properties. J. Org. Chem. 82, 5720–5730 (2017).Article
CAS
PubMed
Google Scholar
Chou, T.-F. et al. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.J. Mol. Biol. 426, 2886–2899 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Briggs, L. C. et al. Analysis of nucleotide binding to P97 reveals the properties of a tandem AAA hexameric ATPase. J. Biol. Chem. 283, 13745–13752 (2008).Article
CAS
PubMed
PubMed Central
Google Scholar
Davies, J. M., Tsuruta, H., May, A. P. & Weis, W. I. Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-Ray scattering. Structure 13, 183–195 (2005).Article
CAS
PubMed
Google Scholar
DeLaBarre, B. & Brunger, A. T. Nucleotide dependent motion and mechanism of action of p97/VCP. J. Mol. Biol. 347, 437–452 (2005).Article
CAS
PubMed
Google Scholar
Huyton, T. et al. The crystal structure of murine p97/VCP at 3.6A. J. Struct. Biol. 144, 337–348 (2003).Article
CAS
PubMed
Google Scholar
Warburg, O., Wind, F. & Negelein, E. The metabolism of tumors in the body. J. Gen. Physiol 8, 519–530 (1927).Article
CAS
PubMed
PubMed Central
Google Scholar
To, C. et al. An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer.Nat Cancer 3, 402–417 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Chou, T.-F. & Deshaies, R. J. Quantitative cell-based protein degradation assays to identify and classify drugs that target the ubiquitin-proteasome system. J. Biol. Chem. 286, 16546–16554 (2011).Article
CAS
PubMed
PubMed Central
Google Scholar
McDermott, M. et al. In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies. Front. Oncol. 4, 40 (2014).Article
PubMed
PubMed Central
Google Scholar
Cheng, A. et al. High resolution single particle cryo-electron microscopy using beam-image shift. J. Struct. Biol 204, 270–275 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).Article
PubMed
Google Scholar
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).Article
CAS
PubMed
Google Scholar
Scheres, S. H. W. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).Article
CAS
PubMed
PubMed Central
Google Scholar
Scheres, S. H. W. & Chen, S. Prevention of overfitting in cryo-EM structure determination. Nat. Methods 9, 853–854 (2012).Article
CAS
PubMed
PubMed Central
Google Scholar
Cardone, G., Heymann, J. B. & Steven, A. C. One number does not fit all: mapping local variations in resolution in cryo-EM reconstructions. J. Struct. Biol. 184, 226–236 (2013).Article
PubMed
Google Scholar
Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).Article
PubMed
PubMed Central
Google Scholar
Grant, T., Rohou, A. & Grigorieff, N. cisTEM, user-friendly software for single-particle image processing. Elife 7, e35383 (2018).Article
PubMed
PubMed Central
Google Scholar
Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63–65 (2014).Article
CAS
PubMed
Google Scholar
Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).Article
CAS
PubMed
Google Scholar
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).Article
PubMed
Google Scholar
Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D Biol. Crystallogr. 65, 1074–1080 (2009).Article
CAS
PubMed
PubMed Central
Google Scholar
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Pintilie, G. et al. Measurement of atom resolvability in cryo-EM maps with Q-scores. Nat. Methods 17, 328–334 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).Article
CAS
PubMed
Google Scholar